Manufacturing / Pharmaceutical Preparations
Gain Therapeutics, Inc.
GANX
$1.64
+$0.03 (+1.55%)
Price as of Oct 9, 2026 21:18 UTC
87 M
Market Cap (Micro Cap)
Nov 10
Next Earnings
Technical Signals
as of Oct 7
Bearish
0 of 7
Trend
- Above 20-day average $1.75
- Above 50-day average $1.80
- Above 200-day average $2.03 · -17.6%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) —
- Momentum cross (20/50) Down · 20d ago
Volume
- Below-average volume 0.8x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for GANX options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Islam Khalid | Grant | 25,000 | $0 | -3.6% | |
| Jul 15, 2026 | Melincoff Gwen A | Grant | 25,000 | $0 | -3.6% | |
| Jul 15, 2026 | Riley Jeffrey Scott | Grant | 25,000 | $0 | -3.6% | |
| Jul 15, 2026 | GOLDSTEIN DOV A MD | Grant | 25,000 | $0 | -3.6% | |
| Jul 15, 2026 | Nicaise Claude | Grant | 25,000 | $0 | -3.6% | |
| Jul 15, 2026 | HASLER HANS PETER | Grant | 25,000 | $0 | -3.6% | |
| Mar 24, 2026 | Fuggetta Gianluca | Grant | 50,000 | $0 | -12.9% | |
| Mar 24, 2026 | Mack Gene | Grant | 200,000 | $0 | -12.9% | |
| Mar 24, 2026 | Mack Gene | Other | 200,000 | $0 | -12.9% | |
| Mar 24, 2026 | Fuggetta Gianluca | Other | 50,000 | $0 | -12.9% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 10, 2026 | Q2 2026 | -$0.14 | |||
| Aug 06, 2026 | Q2 2026 | -$0.14 | |||
| May 12, 2026 | Q1 2026 | -$0.14 | |||
| Mar 31, 2026 | Q1 2026 | -$0.14 | -$0.13 | +7.3% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.15 | -$0.11 | +25.6% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.15 | -$0.15 | +2.0% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.17 | -$0.19 | -10.7% | Miss |
| Mar 31, 2025 | Q1 2025 | -$0.18 | -$0.16 | +12.9% | Beat |
Track GANX with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for GANX and your entire portfolio.